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Abstract: The prevalence of food allergy in childhood appears to be increasing in both developed 11 
and transitional countries. The aim of this paper is to review and summarise key findings in the 12 
prevention and management of food allergy focusing on the role of dietary components and 13 
nutritional habits in the development and optimal functioning of the immune system. Essential fatty 14 
acids, zinc and vitamin D are likely to enhance the anti-inflammatory and antioxidative barrier and 15 
promote immunologic tolerance. Additionally nutritional components such as pre and probiotics 16 
represent a novel research approach in the attempt to induce a tolerogenic immune environment. For 17 
all these reasons, the traditional avoidance diet has been in recent years completely reconsidered. 18 
New findings on the protective effect of an increased diversity of food introduced in the first year 19 
of life on allergic diseases are consistent with the hypothesis that exposure to a variety of food 20 
antigens during early life might play a role in the development of immune tolerance. Accordingly, 21 
therapeutic (and even preventive) interventions should be planned on an individual basis. 22 
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 24 
1. INTRODUCTION 25 
Food allergy (FA) represents a substantial health problem in childhood. The prevalence appears 26 
to be increasing in both developed and transitional countries, however a true increase has been 27 
difficult to demonstrate [1]. Over 90% of food allergies are caused by eight common allergens; 28 
namely: eggs, peanuts, cows’ milk, soy, nuts, shellfish, fish, or wheat [2]. On the whole, food allergy 29 
affects approximately 6% of infants younger than three years [2], and prevalence decreases over the 30 
first decade. The cumulative incidence of food hypersensitivity over a 10-year period is 6.7% (95% 31 
CI: 5.20 to 8.4); 3.0% (95% CI: 1.8–4.2%) had IgE-mediated food allergy and 0.6% (95% CI: 0.07–32 
1.3%) had non-IgE-mediated food allergy/food intolerance [3]. A systematic review from the 33 
European Academy of Allergy and Clinical Immunology concluded that food allergy prevalence in 34 
Europe range between 0.1 to 6.0% [4]. The Institute of Medicine report states that the prevalence of 35 
food allergies in children range between 1.1 – 10.4% [1]. Food allergic infants commonly present 36 
with symptoms and signs of atopic eczema, gastrointestinal symptoms and/or recurrent wheezing [5]. 37 
Diet plays a crucial role in both the prevention and management of food allergy. A number of factors 38 
including the maternal diet, the microbiome and early life feeding have been investigated for the 39 
prevention of allergic diseases [6]. The aim of this paper is to review and summarise key findings in 40 
the prevention and management of food allergy, with particular reference to nutrients of concern (fats, 41 
micronutrients), gut flora (including the role of pre- and probiotics), early life feeding and formula 42 
choice in cows’ milk allergy. 43 
 44 
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2. PREVENTION OF FOOD ALLERGY: THE ROLE OF NUTRITION IN THE 45 
DEVELOPMENT AND OPTIMAL FUNCTIONING OF THE IMMUNE SYSTEM  46 
Allergy results when there is a breakdown in normal “tolerance” mechanisms, which leads to 47 
inappropriate and detrimental immune responses to normally harmless substances, including food 48 
allergens such as cow’s milk protein, eggs, nuts, or shellfish [7]. At birth, the immune system is 49 
immature, but it develops with age, antigen stimulation, and appropriate nutrition [8]. In addition, 50 
bacterial colonization occurs during the first weeks of life, and interactions between intestinal flora 51 
and the developing mucosa result in further development of immune responses and oral tolerance [7]. 52 
Nutrition plays a key role in the development, maintenance, and optimal functioning of immune 53 
cells. Nutrients, such as zinc and vitamin D and nutritional factors, such as pre and probiotics, can 54 
influence the nature of an immune response and are important in ensuring appropriate functioning of 55 
the immune system, as described in the paragraphs below. 56 
 57 
2.1 FAT 58 
Appropriate fat intake may become seriously compromised in allergen-restricted diets and may 59 
be further influenced by the “westernized” dietary practices. The role of fat on the immune system 60 
can be divided into the role of saturated vs. unsaturated fats and the particular role of the essential 61 
fatty acids. 62 
 63 
Saturated vs. unsaturated fats 64 
It has been reported that typical western diets rich in protein and saturated fat and low in 65 
carbohydrates may negatively effect the diversity of the gut microbiome [9]. This was supported by 66 
David et al. [10], showing that an animal based diet high in protein and fat, with very little fibre 67 
intake, resulted in increased abundance of bile-tolerant microorganisms (Alistipes, Bilophila, and 68 
Bacteroides) and decreased levels of Firmicutes that metabolize dietary plant polysaccharides 69 
(Roseburia, Eubacterium rectale, and Ruminococcus bromii) within a five day period. A recent 70 
review also concluded that the amount, type (e.g., unsaturated vs saturated), and mixture of dietary 71 
fats can dramatically shift gut microbial community membership and function [11]. In addition high 72 
fat, high sugar diets also affect the gut barrier function in mice as demonstrated by high horseradish 73 
peroxidase (HRP) influx, lower portal vein endotoxin levels and decreased goblet cell numbers [12]. 74 
The gut barrier function may be permanently affected in non-IgE mediated food allergies and 75 
temporarily affected during allergen exposure in IgE mediated food allergies [13, 14].  76 
Essential fatty acids (EFAs) 77 
EFAs are important immune regulators. Linoleic acid (LA), the parental n-6 polyunsaturated 78 
fatty acid (PUFA), is converted into arachidonic acid (AA) by fatty acid elongase and desaturase, and 79 
subsequently may give origin to pro-inflammatory and pro-allergic lipid mediators, whose cumulative 80 
name is eicosanoids [15]. In contrast, α-linolenic acid (ALA), an n-3 PUFA, is converted in 81 
mammalian body to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are 82 
subsequently converted into anti-inflammatory and/or pro-resolving lipid mediators (such as resolvins 83 
and protectins). EPA forms the precursors of the 3 series of prostaglandins and the 5 series of 84 
leukotrienes, which are biologically less powerful than the corresponding derivatives which form the 85 
n-6 compounds. Because n-3 and n-6 PUFAs compete for the same metabolic pathways, an increase 86 
of n-3 PUFA, parallel to a decrease of n-6 PUFA intake, might theoretically reduce the onset of human 87 
immunologic conditions, including allergies thanks to the replacement of EPA instead AA in the 88 
membranes of inflammatory cells. EFA, including long-chain PUFAs, may be consumed as part of 89 
the normal diet through breast milk, formula and food, or as supplements at any stage in the life cycle 90 
[15]. 91 
The fatty acid status is of particular concern in infants and children. Essential fatty acids (EFA) 92 
promote the renewal of the protective hydrolipidic film layer of the skin and, accordingly, an altered 93 
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EFA metabolism has been associated with the pathogenesis of atopic dermatitis (AD). Moreover the 94 
clinical spectrum of EFA deficiency may range from mild skin irritation to life-threatening conditions 95 
[16]. 96 
In spite of intensive research in the field, a recent systematic review [17] concerning the role of 97 
dietary PUFAs in the development of allergy shows that PUFA supplementation in infancy seems not 98 
to affect infant incidence, childhood incidence or childhood prevalence of food allergy (GRADE level 99 
of evidence: very low) even taking into account a moderate heterogeneity between studies that 100 
reported infant incidence of food allergy (3 studies; 915 infants; RR 0.81, 95% CI 0.56 to 1.19, I2= 101 
63%; RD -0.02, 95% CI -0.06 to 0.02, I2 = 74%). However, well documented immunomodulatory 102 
effects of n-3 PUFAs (both in vitro and in vivo) highlight the potential role in preventing and treating 103 
allergic disease but larger longitudinal intervention studies are clearly warranted to confirm this 104 
observation [18].  105 
 106 
2.2 ZINC 107 
Children with food hypersensitivity have increased amounts of mastocytes, eosinophils and 108 
neutrophils in the digestive tract. Persistent exposure to allergen can lead to chronic inflammatory 109 
changes of mucous membrane and increased production of reactive oxygen species (ROS) [19]. 110 
Excess ROS should be neutralized by components of the antioxidative barrier.  Therefore all 111 
disturbances of enzymatic and non-enzymatic mechanisms of this barrier lead to many unfavourable 112 
reactions including oxidation of cell membrane lipids. Zinc is an essential trace element and it is 113 
needed for various cellular functions, specifically it is a cofactor of many enzymes including 114 
superoxide dismutase (SOD) that play an important role in maintaining the oxidative-antioxidative 115 
balance. A study performed in 134 children with food allergy, aged 1 to 36 months, showed that 116 
children with food allergy had significantly lower concentrations of zinc and therefore a weakened 117 
antioxidative barrier [19]. To our knowledge there are no RCTs investigating zinc supplementation 118 
and allergic outcomes. 119 
 120 
2.3 VITAMIN D 121 
 122 
The classical role of Vitamin D is in fact related to calcium homeostasis and bone health. 123 
However, over the last decade, the effects of vitamin D on the innate and adaptive immune system 124 
have been investigated and expanded [20]. The active form of the vitamin, i.e. 1,25(OH2)D, has 125 
effects on epithelial cells, T cells, B cells, macrophages and dendritic cells. It stimulates innate 126 
immune responses by enhancing the chemotactic and phagocytotic responses of macrophages as well 127 
as the production of antimicrobial proteins such as cathelicidin. This action plays a role in maintaining 128 
the mucosal integrity by stimulating junction genes. Nevertheless, the potential effect of vitamin D 129 
on Th1/Th2 adaptive immune response is of interest and related to food allergy [21, 22, 23]. Almost 130 
all cells of the adaptive immune system express the vitamin D receptor, making them also capable of 131 
being vitamin responsive. When specifically considering a potential role for vitamins in food allergy, 132 
vitamin D has been shown to affect several mechanisms that promote immunologic tolerance, 133 
including T regulatory cell function and the induction of tolerogenic dendritic cells. However clinical 134 
trials on vitamin D supplementation in children and the possible role in preventing food allergy are 135 
lacking. A systematic review of vitamin D supplementation for the prevention of allergic diseases 136 
found no evidences about the protective role of this nutrient in children, but the currently available 137 
data are poor [24]. 138 
 139 
2.4 THE ROLE OF PREBIOTICS, PROBIOTICS AND MICROBIOTA IN THE PREVENTION OF 140 
FOOD ALLERGY 141 
The innate immune system has the ability to modulate adaptive immune responses to food 142 
proteins. Therefore, the type of gastrointestinal microbiota of the newborn and the preservation of 143 
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intestinal permeability is crucial for preventing the development of food allergies. The dietary 144 
modulation of nutritional factors through pre, pro- and synbiotic preparations represent a novel 145 
research hypothesis and a challenge for dietitians and pediatric allergists. The modulation of the 146 
immune system using functional foods is a promising research hypothesis in the attempt to induce a 147 
tolerogenic immune environment [16]. 148 
 149 
Prebiotics 150 
Prebiotics have been defined as “non-digestible food components that beneficially affect the host 151 
by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the 152 
colon and thereby improving host health” and recently redefined as “a selectively fermented 153 
ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal 154 
microbiota that confers benefits” [25]. In December 2016 the panel of expert convened by the 155 
International Scientific Association for Probiotics and Prebiotics (ISAPP) suggested a new definition, 156 
i.e. “a substrate that is selectively utilized by host microorganisms conferring a health benefit” [26].  157 
Based on the body of available evidence, the Guidelines for Atopic Disease Prevention (GLAD-p) 158 
panel concluded that it is likely that prebiotic supplementation in infants reduces the risk of 159 
developing recurrent wheezing and possibly also the development of food allergy. However there is 160 
very low certainty that there is an effect of prebiotics on other outcomes, other than an indirect effect 161 
due to it’s effect on the microbiome. In fact, their activity can be affected by many individual factors, 162 
(e.g. host’s microbiota or the genetic predisposition to diseases). Also environmental factors such as 163 
diet or antibiotics can influence the use of prebiotics [26]. 164 
 165 
Probiotics 166 
Probiotics are living microorganisms that have been proposed as immune-modulators of the 167 
allergic response by affecting phagocytosis and production of pro-inflammatory cytokines, and thus 168 
are being advocated as therapeutic and preventive interventions for allergic diseases [27]. They are 169 
present in everyday food (not only in yoghurt or fermented milk but also in cheese- either hard or 170 
soft, and also in less expected sources such as kefir, miso soup or tempeh) and they are a common 171 
exposure in almost everyone's life [27]. The probiotic effects of complex oligosaccharides in human 172 
milk promote the establishment of a bifidogenic microbiota which, in turn, induces a milieu of 173 
tolerogenic immune responses to foods. Earlier studies suggested a positive effect of probiotic 174 
interventions on atopic dermatitis, but meta-analyses have failed to confirm it. 175 
The new World Allergy Organization (WAO) guidelines determined that it is likely that probiotic 176 
supplementation in infants reduces the risk of developing eczema and suggest that probiotics should 177 
be recommended in mothers of high-risk infants and in infants at high risk of allergic disease, where 178 
“high risk for allergy in a child” is defined as biological parent or sibling with existing or history of 179 
allergic rhinitis, asthma, eczema, or food allergy [27]. The recommendations are conditional and 180 
based on very low quality evidence, with no specific recommendation regarding strains, dose, 181 
treatment duration etc .  182 
In terms of tolerance development in those with established food allergy, one study from 183 
Australia performed oral immunotherapy (OIT) to peanut in combination with Lactabillus GG, 184 
showing that 89.7% of the study participants in this arm were desensitized to peanut. The authors 185 
speculate that this protective effect may be seen because of the possible effect of the probiotic on T-186 
regulatory cells [28]. Further scientific confirmations are required to include probiotics and prebiotics 187 
in the therapeutic plans. Practical implications and how this should be incorporated in advising food 188 
allergy sufferers are also unclear in terms of advising regular intake of foods high in short chain 189 
fructo-oligo saccharides, fermented foods and yoghurts. 190 
3. THE ROLE OF ALLERGEN INTAKE AND DIETARY DIVERSITY IN PREVENTION 191 
OF FOOD ALLERGY 192 
 193 
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3.1 ALLERGEN INTAKE 194 
Measures to prevent allergy and food allergy have traditionally included maternal allergen 195 
avoidance during pregnancy and/or lactation, periods of exclusive breast feeding and avoidance of 196 
potential allergens including food and environmental antigens during the first year of life and beyond 197 
[29]. The value and significance of food avoidance for preventive purposes has been in recent years 198 
completely reconsidered.  199 
On the contrary, an ideal age to introduce potentially allergenic foods into an infant’s diet has 200 
been debated for the past 2 decades, particularly in high-income countries where allergic disease has 201 
become highly prevalent. Initial approaches to primary prevention of food allergy largely focused on 202 
‘‘avoidance’’ strategies. In 2000 [30], practice guidelines generally recommended that allergenic 203 
foods (such as egg, cow’s milk, and peanut) be avoided during the first 1 to 3 years of life. As data 204 
accumulated from both observational studies and experimental models, it became apparent that 205 
avoidance practices may not be beneficial. 206 
Given the increasing interest on the role of time of introduction of allergic food into the infant 207 
diet (the so called “window of opportunity”) and the risk of allergic diseases, intervention trials 208 
evaluating the intake of food, as milk, egg, peanuts etc, during the first year of life have been 209 
performed. 210 
For instance, a recent RCT found no evidence that regular egg intake from age 4 to 6.5 months 211 
substantially alters the risk of egg allergy by age 1 year in infants who are at hereditary risk of allergic 212 
disease and had no eczema symptoms at study entry [31].  These findings are generally supportive 213 
of other data in high-risk patients showing a risk-reducing benefit of early egg introduction, and risk-214 
reducing benefit for early peanut introduction [32]. The EAT study [33] also showed a reduced risk 215 
in the general population using the per protocol analysis but not intention to treat analysis. For peanut, 216 
clinical practice guidelines in the US have incorporated these findings and do recommend early 217 
peanut introduction in the first year of life for high and standard risk children [34]. However, despite 218 
some evidence for early introduction of egg, the US guidelines only made recommendations regarding 219 
peanut intake and concluded that there was not enough evidence to suggest early introduction of egg. 220 
Surprisingly, the UK COT report [35] published very recently, suggested that all foods should be 221 
introduced after a period of exclusive breast feeding from 6 months and that there is no need to 222 
introduce peanut or egg differently from other foods. It seems as if despite the data from recent RCTs 223 
on peanut and egg the weaning debate will continue, as there is still no consensus about the age of 224 
introduction of these foods. The only consistent messages are: Start weaning once the infant is 225 
developmentally ready; Don’t delay introduction of allergens: once they are introduced into the diet, 226 
continue to feed them. 227 
 228 
3.2 DIET DIVERSITY AND OTHER RELATED FACTORS 229 
 230 
Dietary diversity 231 
Recent findings on the protective effect of an increased diversity of food introduced in the first 232 
year of life on allergic diseases (asthma, atopic dermatitis, food allergy and atopic sensitization) are 233 
consistent with the hypothesis that exposure to a variety of food antigens during early life might be 234 
important for the development of immune tolerance [36-38].  235 
The microbiome plays an important role in ensuring the gut wall integrity and regulation of the 236 
immune system. Diet diversity has been shown to reduce allergic diseases [39, 40]. This may well be 237 
that the more diverse diet leads to a more diverse microbiome [41] and that natural microbial load of 238 
food enhances this process [42]. This in turn may improve the gut wall integrity and regulation of the 239 
immune system, but human trials are needed to confirm this theory. 240 
 241 
Food production 242 
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Food production and cooking methods may also affect allergy the immune system (perhaps) via 243 
its effect on the microbiome. Lang et al. [43] reported that the microbial load of different diets (e.g. 244 
USA diet vs. vegan diet) differs due to the foods excluded and cooking methods used. Chaturvedi, et 245 
al. [44] reported that the natural microbial load of fruits and vegetables differ between groups from a 246 
different socio-economic status. In addition Venter and Maslin reported an association seen between 247 
increase in baby food sales and allergic diseases [45], underlining that commercial baby foods are 248 
sterile and that the diversity of ingredients and nutrient content is variable. All these factors highlight 249 
that the foods we eat (irrespective of their nutrient content) may affect the immune system and perhaps 250 
development and management of allergic diseases.  251 
Healthy diet 252 
It is unclear at present what a “healthy diet” in terms of allergy prevention and management means 253 
and if a healthy diet as we know it (20% protein, 50% carbohydrate, 30% fat) has any relevance in 254 
allergy prevention. Currently either the healthy eating index [46] or a mediterranean style diet [47] is 255 
being used as a proxy measure for healthy eating. Research using the healthy eating index tool, 256 
specific to the pregnancy diet, found no association between overall healthy eating score and recurrent 257 
wheeze in infants at the age of 3 years [46] and this was confirmed in a another study by Moonesinghe 258 
et al. focusing on eating patterns in pregnancy and allergic diseases [48]. In addition to these two 259 
studies, two review papers addressed the issue of the mediterranean diet on allergy prevention. Venter 260 
et al. summarised studies during pregnancy [49]. Three observational studies have investigated the 261 
role of the Mediterranean diet on allergy outcomes. One study showed a possible increased risk for 262 
the infant to develop allergic disease [50], one showed a reduction in wheeze [51], and another study  263 
showed no effect on allergy prevention [52]. Mediterranean style eating patterns shows more 264 
promising effects with reduction in asthma/wheezing symptoms seen but no effect on other allergic 265 
symptoms [47]. More studies are therefore needed with well-defined criteria for healthy eating to 266 
study its effect on allergy prevention. 267 
 268 
Other factors 269 
More recently the role of advanced glycosylated end products in food and the direct effect on the 270 
Th2 immune system and the microbiome has been described [53]. One mouse model study also 271 
questioned the role of emulsifiers on the gut microbiome. This study showed that a diet high in 272 
emulsifiers destroyed the epithelial mucous layer in the gut, altered gut microbial composition and 273 
promoted inflammation [54]. 274 
4. THE ROLE OF DIET IN THE MANAGEMENT OF FOOD ALLERGY 275 
The cornerstone of the nutritional management of food allergies is an individualized allergen 276 
avoidance management plan. In children, the main goals are to prevent the occurrence of acute and 277 
chronic symptoms by avoiding the offending food(s), whilst providing an adequate, healthy and 278 
nutritionally balanced diet and maintaining optimal growth; ideally under the guidance of a trained 279 
dietitian [55]. Complete avoidance of the allergen is still required by some, but latest developments 280 
in food allergy have indicated that some individuals with food allergies tolerate baked forms of milk 281 
and egg [56]. Additionally, complete avoidance of all nuts is not necessarily recommended any more, 282 
and only those nuts reactive to, should be eliminated from the diet [57]. In addition to nutritional 283 
consequences of food allergy, it is known that children and families with food allergies experience a 284 
decreased quality of life across a number of domains, which can create anxiety and lead to avoidance 285 
of social situations [58-61]. Hence it is suggested that liberalization of the diet, when appropriate and 286 
safe, will increase both quality of life and nutritional intake.  287 
 288 
4.1 COW’S MILK ALLERGY  289 
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Exclusion of any food group can result in a nutritionally deficient diet, but the elimination of 290 
milk and products in infancy is particularly likely to cause nutritional deficiencies [62] and deserves 291 
special emphasis. Cow’s milk proteins (CM) are among the first foods introduced into an infant’s diet 292 
and accordingly they represent one of the first and most common causes of food allergy in early 293 
childhood. Cows’ milk allergy generally requires a strict exclusion diet usually for the first year of 294 
life. This exclusion of a main food group occurs at a critical time in the development of food 295 
preferences and eating habits. The management of CMA in infants and young children requires 296 
individualized advice regarding avoidance of cows’ milk, including advice to breastfeeding mothers 297 
and/or guidance on the most appropriate specialized formula or milk substitute [63]. In many cases 298 
micronutrient supplements will also be required, however their usage is not always intuitive with both 299 
under and over supplementation occurring [64].  300 
 Cow’s milk proteins could induce an allergic reaction: in particular beta-lactoglobulin (BLG), 301 
included in the whey fraction, is not present in human milk and therefore is considered the principal 302 
component involved in the etiology of the disease. During the production of infant formula, only the 303 
processes of extensive hydrolysis, ultrafiltration or an enzymatic cleavage result in a truly 304 
hypoallergenic formulas [16].   305 
 306 
Choice of formula in CMA 307 
The nutritional value of a milk substitute must be taken into account at ages lower than 2 years 308 
of life when such a type of food is needed [16]. As breast milk composition differs both in component 309 
ratios and structure from other milks, the composition of infant formula should serve to meet the 310 
particular nutritional requirements and to promote normal growth and development of the infants for 311 
whom they are intended [65, 66]. When a replacement formula is needed, allergologists can avail 312 
themselves with different types of formula [67]. The alternative formulas considered for CMA are 313 
extensively hydrolyzed whey or casein formula (eHWF or eHCF) and amino acid-based formula 314 
(AAF), which are considered of low antigenic potential and are therefore preferred in highly allergic 315 
children. The unpalatable taste of hydrolyzed formulas has often been associated with reduced intakes 316 
and a consequent growth faltering in infants fed these types of formula, particularly in the first year 317 
of life [62].  318 
In recent years, an alternative explanation has been proposed based on the content of free amino 319 
acids (FAAs) in hydrolyzed formulas, added to complete their biologic value. Glutamic acid, in 320 
particular, has been suggested to downregulate appetite during feeding by interacting with specific 321 
receptors in the oral cavity and gastrointestinal tract. However recent studies have shown no negative 322 
effect of feeding AA formulas in infants, in contrary, they may be beneficial for growth [68].  323 
 324 
Other studies have demonstrated that dietary management with extensively hydrolysed casein-325 
based formula (EHCF) supplemented with the probiotic Lactobacillus rhamnosus GG (LGG) results 326 
in a higher rate of tolerance acquisition in infants with CMA than in those treated with EHCF without 327 
supplementation or with other noncasein-based formulas. The mechanistic basis for this effect could 328 
be the possible influence of EHCF+LGG on the strain-level bacterial community structure of the 329 
infant gut [69]. However, randomised controlled trials to date have not yielded sufficient evidence to 330 
recommend probiotics for the primary prevention of allergic disorders. Indeed, the Nutrition 331 
Committee of the European Society for Paediatric Gastroenterology Hepatology and Nutrition 332 
(ESPGHAN) does not support routine supplementing with probiotics in infant formulas [70]. 333 
 334 
Soy protein–based formula may be an option in infants older than 6 months who do not accept 335 
the bitter taste of an eHF, or in cases in which the higher cost of an eHF is a limiting factor [71]. 336 
However, soy formulae have nutritional disadvantages because their absorption of minerals and trace 337 
elements may be lower because of their phytate content, and they contain appreciable amounts of 338 
isoflavones with a potentially weak estrogenic action that can lead to high serum concentrations in 339 
infants. Also the possible derivation from genetic modified soy should be considered. Hence, the 340 
European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) and the 341 
American Academy of Pediatrics (AAP) recommend that cow’s-milk–based formulae should be 342 
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preferred over soy formula in healthy infants, and soy protein– based formulae should not usually be 343 
used during the first 6 months of life [71]. 344 
 345 
Other mammal’s milks, those of, goats, ewe’s , mare, donkey, or camel have been proposed as 346 
substitutes in the management of CMA in infants and children, but are NOT recommended due to 347 
either nutritional issues, cross-reactions or both. The DRACMA guidelines state that milk allergens 348 
of various mammalian species cross-react [16]. The greatest homology is found between a cow’s, 349 
buffalo’s, sheep’s and goat’s milks protein. Proteins in their milks have less structural similarity with 350 
pig, horse, donkey, camel and dromedary. Goats, buffalo and ewe’s milk are particularly not 351 
recommended by the World Allergy Organization due to cross-reactivity with cow’s milk [16]. The 352 
tolerance of other mammalian milks needs to be further investigated in clinical trials and there are 353 
some concerns about their chemical composition and sanitation. In conclusion, either amino acid-354 
based formulas or extensively HF represent the most available solutions for allergic infants no longer 355 
breast-fed. The therapeutic interventions should be therefore indicated on an individual basis.  356 
5. CONCLUSION 357 
Food allergy represents a significant health burden on an individual and population level 358 
worldwide. Recent guidelines for the prevention of food allergies advocate that there is no need to 359 
delay the introduction of allergenic foods once weaning has commenced. In terms of food allergy 360 
management (end even prevention), individualized strategies should be implemented. These 361 
strategies will include development readiness to be weaned, prevalence of particular food allergies in 362 
certain countries, family eating patterns and availability of physician and dietetic care. 363 
Care should be taken to ensure adequate intake of nutrients, particularly in relation to cow’s milk 364 
allergy, when selecting a suitable hypoallergenic formula. There is emerging evidence regarding the 365 
role of fats (particularly AGEs), pre/probiotics, commercial foods, healthy eating and micronutrients 366 
on food allergy. A better understanding of how nutrients and other aspects of food, food patterns and 367 
food preparation may affect the immune system and allergy outcomes is required to best advise those 368 
at risk of developing food allergies and those with current food allergies. 369 
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